EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intranasal Delivery of Gallium–Quercetin Nanoparticles for Multi‐Target Ferroptosis Inhibition in Parkinson's Disease

Keyang Xu, Dandan Kou, Xiao Xiao, Bingbing Bai iD, Caide Liu iD, Mengyao Wu, Yadan Shi, Mengdan Xu, Xiaoyi Cao, Haodi Qi, Shuhua Wu iD, Jianfeng Zeng iD und 1 weitere

Advanced Science · 2026

DOI: 10.1002/advs.77025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Keyang Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Soochow University, School of Radiation Medicine and Protection, Soochow University, Suzhou…. Hauptthemen laut MEDLINE: Quercetin, Ferroptosis, Gallium, Parkinson Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Suzhou Fundamental Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis contributes to Parkinson's disease (PD) through interconnected processes including iron dysregulation, oxidative stress, and mitochondrial dysfunction, yet current therapies targeting single pathways remain insufficient. Herein, we developed gallium–quercetin nanoparticles (GQNPs) as an intranasally deliverable nanoplatform for multi‐target ferroptosis inhibition. In vitro, GQNPs suppressed ferroptosis by coordinating iron regulation and antioxidation. Ga 3 + interfered with transferrin‐mediated iron uptake to restrict iron influx, while quercetin reduced oxidative stress and supported iron homeostasis, thereby decreasing ROS accumulation and improving mitochondrial function. In vivo, intranasal delivery of GQNPs effectively bypassed the blood‐brain barrier to recover motor coordination and cognitive function in PD mice. By integrating iron regulation, antioxidant activity, and mitochondrial protection within a single nanoplatform, this work highlights gallium‐based coordination nanoparticles as a promising therapeutic strategy for ferroptosis‐associated neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinFerroptosisGalliumParkinson DiseaseNanoparticlesAnimalsAdministration, IntranasalMiceHumansOxidative StressIron

Stichwörter der Autor:innen

Parkinson's disease therapyferroptosis inhibitiongallium quercetin nanoparticlesintranasal drug deliveryiron metabolism regulation

Substanzen

QuercetinGalliumIron

Autor:innen und Institutionen

  • Department of Radiology, The First Affiliated Hospital of Soochow University, School of Radiation Medicine and Protection, Soochow University, Suzhou, China.
  • General Dentistry Department, The Stomatology Hospital Affiliated of Suzhou Vocational Health College, Suzhou, China.
  • Medical School of Nanjing University, Nanjing, China.
  • The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Biomedical Basic Research Center (BBRC) of Jiangsu Province, Suzhou, China.
  • School of Life Sciences, Soochow University, Suzhou, China.

ORCID-Profile: Bingbing Bai, Caide Liu, Shuhua Wu, Jianfeng Zeng

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Suzhou Fundamental Research Project

Zitieren

APA

Xu, K., Kou, D., Xiao, X., Bai, B., Liu, C., Wu, M., Shi, Y., Xu, M., Cao, X., Qi, H., Wu, S., Zeng, J., & Gao, M. (2026). Intranasal Delivery of Gallium–Quercetin Nanoparticles for Multi‐Target Ferroptosis Inhibition in Parkinson's Disease. Advanced Science. https://doi.org/10.1002/advs.77025

Vancouver

Xu K, Kou D, Xiao X, Bai B, Liu C, Wu M, et al. Intranasal Delivery of Gallium–Quercetin Nanoparticles for Multi‐Target Ferroptosis Inhibition in Parkinson's Disease. Advanced Science. 2026. doi:10.1002/advs.77025

BibTeX
@article{Xu2026,
  author = {Xu, Keyang and Kou, Dandan and Xiao, Xiao and Bai, Bingbing and Liu, Caide and Wu, Mengyao and Shi, Yadan and Xu, Mengdan and Cao, Xiaoyi and Qi, Haodi and Wu, Shuhua and Zeng, Jianfeng and Gao, Mingyuan},
  title = {Intranasal Delivery of Gallium–Quercetin Nanoparticles for Multi‐Target Ferroptosis Inhibition in Parkinson's Disease},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.77025}
}
Kostenlos starten →